StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.14−0.13 (-1.57%)

Close on Nov 19, 2026Market cap $283.95MP/E –Yield –

Benitec Biopharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Benitec Biopharma's price to sales ratio was 429.5× on Jan 31, 2024, against 48.9× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 2024429.5×−64.2
2023Dec 29, 2023493.7×+405.4
2022Oct 31, 202288.3×+49.9
2020Jul 31, 202038.4×−2.7
2019Dec 31, 201941.1×–

More Benitec Biopharma figures

See a number that looks wrong?